C-squared Pharma Ltd, based in Ireland, is a pharmaceutical company.
One of their notable products is BIMATOPROST, with a corresponding US DMF Number 25903.
Remarkably, this DMF maintains an Active status since its submission on March 19, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 08, 2013, and payment made on December 24, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II